Biotechnology - MIDA | Malaysian Investment Development Authority
EnglishB. MelayuDeutsch日本語简体中文한국어
contrastBtngrayscaleBtn oku-icon


plusBtn crossBtn minusBtn


This site
is mobile




BioNexus status is awarded to qualified biotechnology firms engaged in value-added activities within biotech and life sciences. This status grants companies fiscal incentives, funds, and support for growth. Companies with BioNexus status benefit from guarantees outlined in the BioNexus Status Bill, including ownership freedom, access to shared labs, research centres, and continuous assistance from the Malaysian Bioeconomy Development Corporation (MBDC) under the Ministry of Science, Technology, and Innovation (MOSTI).

The recently launched National Biotechnology Policy 2.0 (NBP 2.0) facilitates industry advancement through cutting-edge technology adoption. NBP 2.0 aids industries in ascending the value chain to compete globally in agriculture, food security, healthcare, well-being, and the circular economy.

To drive industry growth, the government encourages involvement from stakeholders such as MBDC to enhance the BioNexus Bill of Guarantees, National Institutes of Biotechnology Malaysia (NIBM) to fortify R&D facilities, local venture capital companies and government-linked entities to support the industry’s expansion, and commercial banks to provide financing.

An additional RM5 million funding Is designated for the Bio-based Accelerator (BBA) programme to boost local biotech companies. The government seeks to attract more local and foreign industry players to partake in this flourishing high-value, high-tech sector.

RM139.3 million

Total Approved Investments in 2022

For more statistics, please click here.

Biotechnology Growth Potential




Our Investors' Highlights

We are pleased to support the Ministry of Health of Malaysia in providing high quality, affordable, rh-insulin for people with diabetes in Malaysia. It is a matter of pride that this is a ‘Made in Malaysia’ insulin product manufactured by Biocon Sdn. Bhd. at the Biotech Park in Iskandar Puteri, Johor. We expect our Malaysian facility to cater to the growing needs for affordable insulins across the globe.

- Kiran Mazumdar-Shaw
Chairperson & Managing Director Biocon Limited (2020)

Get Started

MIDA provides comprehensive support to your business as you consider the competitive and comparative advantages Malaysia has to offer for your investment. Explore our dedicated resources, wide range of facilities or consultation services to assist you in expanding your operations here.
Learn more about the essential forms and guidelines to help you get started on your journey in Malaysia’s manufacturing sector.
Submit your application for a Manufacturing License or other incentives here.